+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Nicotine Replacement Therapy Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805823
The global nicotine replacement therapy market size attained a value of USD 3.09 billion in 2022. The market is anticipated to grow at a CAGR of 9.3% during the forecast period of 2023-2031 to attain a value of USD 6.85 billion by 2031.

Nicotine Replacement Therapy Market: Introduction

Nicotine replacement therapy (NRT) refers to a medically approved way to take nicotine without using tobacco. It is a treatment designed to help people quit smoking by easing the withdrawal symptoms from nicotine, the addictive substance in tobacco. NRT comes in several forms, including skin patches, chewing gum, nasal spray, inhalers, and lozenges.

Nicotine replacement therapy is based on the understanding that nicotine addiction is not just a simple habit but a complex interplay of physical and psychological dependencies. When a person attempts to quit smoking, they not only miss the physical act of smoking but also suffer from nicotine withdrawal symptoms like irritability, anxiety, difficulty concentrating, and increased appetite. NRT helps to address the physical dependency by providing a controlled supply of nicotine, minus the harmful substances found in tobacco. This approach allows the individual to focus on the behavioural aspects of quitting.

Benefits of Nicotine Replacement Therapy:
  • Eases Withdrawal Symptoms: NRT helps manage withdrawal symptoms by providing a controlled and safe dose of nicotine. This eases symptoms like irritability, anxiety, restlessness, and cravings associated with nicotine withdrawal
  • Improves Quit Rates: NRT can double the chances of successfully quitting smoking, especially when combined with behavioural support
  • Flexibility: NRT products are available in various forms, allowing individuals to choose a method that best suits their needs and lifestyle. Some people may prefer a patch for sustained relief, while others may prefer gum or lozenges for more immediate relief
  • Reduced Harm: By delivering nicotine without the harmful substances in tobacco smoke (like tar and carbon monoxide), NRT reduces the harm associated with smoking
  • Gradual Weaning: NRT allows for a gradual reduction in nicotine intake, which can be less distressing than abrupt cessation
While NRT is a valuable tool in smoking cessation, it is important to remember that quitting smoking often requires a comprehensive approach, including behavioural changes and support. Also, while NRT is generally safe for most adults, it is recommended to consult with a healthcare provider before starting NRT, especially for those with specific health conditions.

Nicotine Replacement Therapy Market Segmentations

The market can be categorised into product type, end user, and region.

Market Breakup by Product Type

  • Patches
  • Gums
  • Logenzes Inhalers
  • Nasal Spray
  • Sublingual Tablets

Market Breakup by End User

  • Hospital
  • Pharmacy
  • Others

Nicotine Replacement Therapy Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Nicotine Replacement Therapy Market Scenario

The nicotine replacement therapy (NRT) market is currently witnessing a significant upswing due to several factors. The primary driver is the increasing global smoking population coupled with a rising awareness about the health risks associated with smoking. The detrimental effects of smoking on health, including increased risk of cancer, cardiovascular disease, and respiratory conditions, have been well documented. This awareness has led to an increased demand for effective smoking cessation aids such as NRT products.

Another significant factor is the ongoing support from various governments and health organizations worldwide. These entities are putting significant efforts into anti-smoking campaigns and providing subsidies for smoking cessation products, further propelling the NRT market growth. Moreover, initiatives by major companies in the market to increase awareness and availability of their products also contribute to the overall growth.

The market is segmented based on the type of NRT products, including patches, gums, lozenges, inhalers, and nasal sprays. Among these, nicotine gums and patches are currently leading in terms of market share due to their ease of use, availability, and relative effectiveness.

Geographically, North America and Europe hold significant market shares, mainly due to high smoking rates in these regions, strong healthcare infrastructure, and extensive anti-smoking campaigns. However, the Asia Pacific region is projected to witness substantial growth in the coming years due to the rising prevalence of smoking, increasing disposable income, and improving healthcare infrastructure.

Despite the encouraging growth, the NRT market faces some challenges. These include the potential side effects of NRT products, the availability of alternative smoking cessation methods like e-cigarettes and non-nicotine medications, and the high rate of relapse among smokers.

Nevertheless, the overall market outlook for NRT remains optimistic, given the increasing global smoking population and rising awareness about the health risks of smoking. The continuous development and introduction of more effective and user-friendly NRT products also bode well for the future growth of this market.

Key Players in the Global Nicotine Replacement Therapy Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the nicotine replacement therapy market are as follows:
  • Pfizer Inc
  • GlaxoSmithKline plc
  • Novartis AG
  • Mylan N.V
  • Teva Pharmaceutical Industries Ltd
  • Sanofi
  • AstraZeneca
  • Johnson & Johnson
  • Merck & Co
  • Cipla

Table of Contents

1 Preface2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Nicotine Replacement Therapy Market Analysis
8.1 Key Industry Highlights
8.2 Global Nicotine Replacement Therapy Historical Market (2018-2022)
8.3 Global Nicotine Replacement Therapy Market Forecast (2023-2028)
8.4 Global Nicotine Replacement Therapy Market by Product
8.4.1 Nicotine Replacement Therapy (NRT)
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.1.3 Breakup by Type
8.4.1.3.1 Inhalers
8.4.1.3.2 Gum
8.4.1.3.3 Transdermal Patches
8.4.1.3.4 Sublingual Tablets
8.4.1.3.5 Lozenges
8.4.1.3.6 Others
8.4.2 E-cigarettes
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.4.3 Heat-not-burn Tobacco Products
8.4.3.1 Historical Trend (2018-2022)
8.4.3.2 Forecast Trend (2023-2028)
8.5 Global Nicotine Replacement Therapy Market by Distribution Channel
8.5.1 Offline
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Online
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.6 Global Nicotine Replacement Therapy Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2022)
8.6.3.2 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2022)
8.6.4.2 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2022)
8.6.5.2 Forecast Trend (2023-2028)
9 North America Nicotine Replacement Therapy Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Nicotine Replacement Therapy Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Nicotine Replacement Therapy Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Nicotine Replacement Therapy Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Nicotine Replacement Therapy Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Cipla Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Pfizer Inc.
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Glenmark Pharmaceuticals Limited
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Fertin Pharma A/S
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Philip Morris International Inc.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 British American Tobacco plc
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Imperial Brands plc
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Japan Tobacco Inc.
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 Johnson and Johnson Private Limited
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Others
16 Key Trends and Developments in the Market

Companies Mentioned

  • Cipla Inc.
  • Pfizer Inc.
  • Glenmark Pharmaceuticals Limited
  • Fertin Pharma A/S,
  • Philip Morris International Inc.
  • British American Tobacco plc
  • Imperial Brands plc,
  • Japan Tobacco Inc.
  • Johnson and Johnson Private Limited

Methodology

Loading
LOADING...

Table Information